An Open Label, Randomized, Single Dose, Crossover Study to Evaluate the Pharmacokinetics and Safety of DA-5213 10mg in Healthy Subjects
An Open Label, Randomized, Single Dose, Crossover Study to Evaluate the Pharmacokinetics and Safety of DA-5213 10mg in Healthy Subjects
Phamacokinetics and safety profiles of DA-5213 10mg in Healthy subjects
Inclusion Criteria:
Exclusion Criteria:
Siheung-si, Gyeonggi-do 15079, South Korea